October 5, 2023
AstraZeneca settles Nexium and Prilosec product liability litigations
AstraZeneca said Tuesday it has made agreements in the product liability litigations related to Nexium and Prilosec. The company said…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
October 4, 2023
Moderna’s combo vaccine shows strong immunogenicity against influenza and COVID-19
Moderna announced Wednesday positive results from a clinical trial of mRNA-1083, its combination mRNA combination flu/COVID vaccine.
October 4, 2023
Mainz Biomed launches ColoAlert with Bioclinica in Romania
Mainz Biomed, a molecular genetics diagnostic company specializing in the early detection of cancer, has launched its flagship product, ColoAlert — a highly effective and user-friendly at-home detection test for colorectal cancer (CRC) – with its partner Bioclinica, a leader in the Romanian healthcare sector.
October 3, 2023
Exscientia sees maintaining cash runway well into 2026
Exscientia provided Tuesday an update on its pipeline prioritisation strategy designed to further strengthen the Company’s focus, investment and infrastructure on programmes of greatest potential for differentiation and value creation, outlinging strategy which will support continued investment into market-leading technology while maintaining cash runway well into 2026.
October 3, 2023
Cancer cases and deaths on the rise in the EU
New cancer cases rose by 2.3 % compared to 2020, to reach 2.74 million in 2022. Similarly, cancer deaths went up by 2.4 % compared to 2020, according to the European Commission’s estimates published in the European Cancer Information System (ECIS).
October 3, 2023
Novartis reports positive data from the Phase III APPLAUSE study which reinforces the potential of iptacopan
Novartis announced Monday positive top-line results from the pre-specified interim analysis of the Phase III APPLAUSE-IgAN study (NCT04578834) at 9 months.
October 3, 2023
EUCAIM kicks off first platform to fuel collaborative innovation and data sharing across Europe
The EUCAIM consortium and the European Commission have the first public release of its platform, Cancer Image Europe, marking a major milestone in the project’s development and an exciting step towards achieving its vision and goals.
October 2, 2023
Arecor Therapeutics brings more subjects Phase I trial of its insulin candidate
Arecor Therapeutics has decided to increase the number of subjects within its ongoing Phase I clinical trial of ultra-rapid, ultra-concentrated insulin candidate AT278, in line with the update provided within its Interim Results on 14 September.
October 2, 2023
Poolbeg welcomes cancelling patent opposition hearing
Poolbeg Pharma, a clinical-stage biopharmaceutical company, said last week that further to its announcement on 19 September 2023, the oral opposition hearing scheduled by the European Patent Office (‘EPO’) relating to the challenge to the Company’s European patent (Immunomodulator I), has been cancelled.
October 2, 2023
FDA acceptance Basilea’s New Drug Application for antibiotic ceftobiprole
A commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial or fungal infections, Basilea Pharmaceutica, said…